Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shobhit Kumar

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Virology|January 9, 2025
Synergistic inhibition of HIV-1 by Nelfinavir and Epigallocatechin Gallate: A novel nanoemulsion-based therapeutic approachShraddha Y Gaikwad, Ashwini More, Chandrabhan Seniya, et al.
Scientific Reports|June 9, 2026
Mesoporous silica nanoparticle-mediated delivery of a synergistic 5-miRNA combination inhibits HSV-2 infectionDebashree Dass, Anwesha Banerjee, N S Suneesh, et al.
Current Pharmaceutical Design|April 19, 2020
Ligand Conjugated Targeted Nanotherapeutics for Treatment of Neurological DisordersSaurabh Mittal, Muhammad U Ashhar, Farheen F Qizilbash, et al.
Journal of Indian Society of Periodontology|September 15, 2025
Combination of metronidazole and green tea extract-loaded nanoparticles: Formulation, optimization, <i>in vitro</i> and <i>ex vivo</i> study for the treatment of periodontal diseaseArshi Chaudhary, Ali Sartaj, Nilima Sharma, et al.
Journal of Drug Targeting|August 1, 2023
Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cellsFarheen Fatima Qizilbash, Ali Sartaj, Zufika Qamar, et al.
Oncology Research|April 30, 2024
Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrierKaran Wadhwa, Payal Chauhan, Shobhit Kumar, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2020
A systematic review of the smartphone applications available for coronavirus disease 2019 (COVID19) and their assessment using the mobile app rating scale (MARS)Samira Davalbhakta, Shailesh Advani, Shobhit Kumar, et al.
Current Drug Delivery|July 31, 2023
Monoclonal Antibodies and Antibody-drug Conjugates as Emerging Therapeutics for Breast Cancer TreatmentSwati Saini, Nisha Gulati, Rajendra Awasthi, et al.
Journal of Medical Systems|August 12, 2020
A Systematic Review of Smartphone Applications Available for Corona Virus Disease 2019 (COVID19) and the Assessment of their Quality Using the Mobile Application Rating Scale (MARS)Samira Davalbhakta, Shailesh Advani, Shobhit Kumar, et al.
Molecules (Basel, Switzerland)|August 26, 2022
Mechanistic Insights into the Pharmacological Significance of SilymarinKaran Wadhwa, Rakesh Pahwa, Manish Kumar, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Virology|January 9, 2025
Synergistic inhibition of HIV-1 by Nelfinavir and Epigallocatechin Gallate: A novel nanoemulsion-based therapeutic approachShraddha Y Gaikwad, Ashwini More, Chandrabhan Seniya, et al.
Scientific Reports|June 9, 2026
Mesoporous silica nanoparticle-mediated delivery of a synergistic 5-miRNA combination inhibits HSV-2 infectionDebashree Dass, Anwesha Banerjee, N S Suneesh, et al.
Current Pharmaceutical Design|April 19, 2020
Ligand Conjugated Targeted Nanotherapeutics for Treatment of Neurological DisordersSaurabh Mittal, Muhammad U Ashhar, Farheen F Qizilbash, et al.
Journal of Indian Society of Periodontology|September 15, 2025
Combination of metronidazole and green tea extract-loaded nanoparticles: Formulation, optimization, <i>in vitro</i> and <i>ex vivo</i> study for the treatment of periodontal diseaseArshi Chaudhary, Ali Sartaj, Nilima Sharma, et al.
Journal of Drug Targeting|August 1, 2023
Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cellsFarheen Fatima Qizilbash, Ali Sartaj, Zufika Qamar, et al.
Oncology Research|April 30, 2024
Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrierKaran Wadhwa, Payal Chauhan, Shobhit Kumar, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2020
A systematic review of the smartphone applications available for coronavirus disease 2019 (COVID19) and their assessment using the mobile app rating scale (MARS)Samira Davalbhakta, Shailesh Advani, Shobhit Kumar, et al.
Current Drug Delivery|July 31, 2023
Monoclonal Antibodies and Antibody-drug Conjugates as Emerging Therapeutics for Breast Cancer TreatmentSwati Saini, Nisha Gulati, Rajendra Awasthi, et al.
Journal of Medical Systems|August 12, 2020
A Systematic Review of Smartphone Applications Available for Corona Virus Disease 2019 (COVID19) and the Assessment of their Quality Using the Mobile Application Rating Scale (MARS)Samira Davalbhakta, Shailesh Advani, Shobhit Kumar, et al.
Molecules (Basel, Switzerland)|August 26, 2022
Mechanistic Insights into the Pharmacological Significance of SilymarinKaran Wadhwa, Rakesh Pahwa, Manish Kumar, et al.
Pageof 6